fifteen patients with intracranial or spinal meningiomas have been treated with the semisynthetic progestational agent medroxyprogesterone acetate ( mpa , depo-provera ) prior to surgical removal of the tumors in order to investigate the influence of mpa on the progesterone receptor ( pr ) status of meningioma cytosols .
C0065864
medroxyprogesterone acetate
C0699700
depo-provera